In situ mapping of HSA reabsorption by a NIR fluorogenic sensor as a practical phenotypic assay for nephroprotective drug discovery

Key Points

• Mapping HSA reabsorption demonstrates the effectiveness of using a NIR fluorogenic sensor in nephroprotective assays.
• Key findings reveal that this method could enhance the drug discovery process, potentially influencing future pharmaceutics.
• Analysis employs an innovative fluorogenic sensor to pinpoint reabsorption processes in real time, facilitating immediate application in research settings.
• Implications highlight the potential for this mapping approach to streamline nephroprotective drug development, though additional validation may be required.